Skip to main content

Table 1 Patient characteristics (n = 73)

From: Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer

Age, Md (IQR; range) 64 (58–66; 49–79)
BMI, Md (IQR; range) 26.3 (24.2–29.9; 20–41), n = 69
Left-sided BC, n (%) 50 (68.5)
AI use, n (%) 26 (35.6)
Tamoxifen use, n (%) 6 (8.2)
ACE or ARB use, n (%) 22 (30.1)
ASA use, n (%) 8 (11.0)
Beta-blocker use, n (%) 12 (16.4)
Statin use, n (%) 15 (20.5)
CAD, n (%) 3 (4.1)
Diabetes, n (%) 6 (8.2), n = 69
Hypertension, n (%) 30 (41.1)
Hypothyroidism, n (%) 12 (16.4)
Smoking, n (%) 8 (11)
  1. Md median, IQR interquartile range, BMI body mass index, BC breast cancer, AI aromatase inhibitor, ACE angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, ASA low dose acetylsalicylic acid, CAD coronary artery disease, Diabetes use of diabetes medication